ABEO stock news

LOS ANGELES--(BUSINESS WIRE)---- $ABEO #ABEO--THURSDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abeona Therapeutics Inc. Read more

Investors who purchased the Company's securities between May 31, 2018 and September 23, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 2, 2020. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian Read more

Investors who purchased the Company's securities between May 31, 2018 and September 23, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 2, 2020. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian Read more

NEW YORK--(BUSINESS WIRE)-- #abeo--Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Abeona Therapeutics, Inc. (NASDAQ: ABEO) securities between May 31, 2018 and September 23, 2019 (the “Class Period”). Investors have until January 2, 2019 to apply to the Court to be appointed as lead plaintiff in the la Read more

LOS ANGELES, CA / ACCESSWIRE / December 20, 2019 / The Schall Law Firm ,a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Abeona Therapeutics Inc. ("Abeona" … Read more

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 19.) Acceleron Pharma Inc (NASDAQ: XLRN ) Ardelyx Inc (NASDAQ: ARDX ) AstraZeneca plc (NYSE: AZN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) (priced its 2-million-share common stock offering at $87 per share) Clearside Biomedical Inc (NASDAQ: CLSD ) Cortexyme Inc (NASDAQ: CRTX ) Cue Biopharma Inc (NASDAQ: CUE ) Exagen Inc (NASDAQ: XGN ) Globus Medical Inc (NYSE: GMED ) Horizon Therapeutics PLC (NASDAQ: HZNP ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) (The acquisition vehicle announced merger with Immuvant, a clinical-stage biopharma company focusing on autoimmune disorders) IVERIC bio Inc (NASDAQ: ISEE ) Johnson & Johnson (NYSE: JNJ ) (Barclays upgraded shares to Overweight) The Medicines Company (NASDAQ: MDCO ) Merck & Co., Inc. (NYSE: MRK ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Monopar Therapeutics Inc. (NASDAQ: MNPR ) (Went public Thursday) Myokardia Inc (NASDAQ: MYOK ) NeoGenomics, Inc. (NASDAQ: NEO ) Novan Inc (NASDAQ: NOVN ) Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP ) Principia Biopharma Inc (NASDAQ: PRNB ) Quest Diagnostics Inc (NYSE: DGX ) Recro Pharma Inc (NASDAQ: REPH ) Sanofi SA (NASDAQ: SNY ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Down In The Dumps (Biotech stocks that hit 52-week lows Dec. 19.) Aethlon Medical, Inc. (NASDAQ: AEMD ) Anixa Biosciences Inc (NASDAQ: ANIX ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Correvio Pharma Corp (NASDAQ: … Read more

Investors who purchased the Company's securities between May 31, 2018 and September 23, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 2, 2020. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian Read more

The company announced that the US Food and Drug Administration has removed its clinical hold on its Phase 3 clinical trial of EB-101. The post Abeona Therapeutics to Initiate Phase 3 Clinical Trial of B-101 appeared first on Investing News Network . Read more

NEW YORK, NY / ACCESSWIRE / December 9, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review … Read more

Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD ) announced a deal late Monday to be acquired by Japanese pharma company ASTELLAS PHARMA/ADR (OTC: ALPMY ) for $60 per share, representing a 110% premium over Audentes' Monday closing price. Audentes shares are trading close to the offer price, and the news has lifted other gene therapy names. The movers include: Uniqure NV (NASDAQ: QURE ), up 15.92% to $63.50. Uniqure's CEO is also participating in a fireside chat at the Piper Jaffray Healthcare Conference Tuesday. Abeona Therapeutics Inc (NASDAQ: ABEO ), up 1.17%% to $3.45. Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ), up 4.72% to $11.53. Regenxbio Inc (NASDAQ: RGNX ), up 9.76% to $44.65. Sangamo Therapeutics Inc (NASDAQ: SGMO ), up 6.27% to $11.36. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ), up 0.28% to $80.08. Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ), … Full story available on Benzinga.com Read more

LOS ANGELES, CA / ACCESSWIRE / November 27, 2019 / The Schall Law Firm ,a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Abeona Therapeutics Inc. ("Abeona" … Read more

NEW YORK, NY / ACCESSWIRE / November 25, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can … Read more

LOS ANGELES, CA / ACCESSWIRE / November 22, 2019 / The Schall Law Firm ,a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Abeona Therapeutics Inc. ("Abeona" … Read more

Zhang Investor Law announces a securities class action lawsuit on behalf of shareholders who bought shares of Abeona Therapeutics Inc. (ABEO) between May 31, 2018 and September 23, 2019, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than January Read more

NEW YORK, NY / ACCESSWIRE / November 20, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can … Read more